Medgenics gets patent for EPO pump; Alexza's Adusave aerosol loxapine coming closer to market;

> Adusave, aerosol-delivered loxapine using Alexza Pharmaceuticals' ($ALXA) Staccato delivery system, could gain approval in the U.S. and Europe next month. Article | Press release

> Medgenics' ($MDGN) Epodure Biopump technology has been granted a U.S. patent for the delivery of erythropoietin (EPO). Article

> Impax Laboratories and Perrigo are working together to develop, manufacture, and commercialize a topical generic drug. Article

> Sanovas has received a patent for its nested balloon catheter for localized drug delivery, part of its Vas Zeppelin Smart Catheter technology portfolio. Article

> Alliqua is looking into using its proprietary transdermal delivery platform in the cosmeceutical industry. Press release

> Italian researchers are developing niosomes to deliver anti-inflammatory drugs. Article

And Finally… Whipworm infection could alleviate autism--a novel drug delivery device? Article

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.